Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.58 HKD
1.07 B HKD
4.99 B HKD
254.51 M
About CHINA SHINEWAY PHARMACEUTICAL GR
China Shineway Pharmaceutical Group Ltd. is an investment holding company, which engages in the research and development, manufacturing, and trading of Chinese pharmaceutical products. Its products include Shen Mai injection, Qing Kai Ling injection, and Wu Fu Xin Nao Qing soft capsule. The company was founded by Zhen Jiang Li and Yun Xia Xin on August 14, 2002 and is headquartered in Shijiazhuang, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 2877 is 9.93 HKD — it has increased by 1.95% in the past 24 hours. Watch CHINA SHINEWAY PHARMACEUTICAL GR stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange CHINA SHINEWAY PHARMACEUTICAL GR stocks are traded under the ticker 2877.
2877 stock has risen by 7.93% compared to the previous week, the month change is a 19.93% rise, over the last year CHINA SHINEWAY PHARMACEUTICAL GR has showed a 45.60% increase.
We've gathered analysts' opinions on CHINA SHINEWAY PHARMACEUTICAL GR future price: according to them, 2877 price has a max estimate of 17.64 HKD and a min estimate of 9.96 HKD. Watch 2877 chart and read a more detailed CHINA SHINEWAY PHARMACEUTICAL GR stock forecast: see what analysts think of CHINA SHINEWAY PHARMACEUTICAL GR and suggest that you do with its stocks.
2877 reached its all-time high on Nov 3, 2010 with the price of 29.30 HKD, and its all-time low was 2.08 HKD and was reached on Aug 11, 2005. View more price dynamics on 2877 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
2877 stock is 7.19% volatile and has beta coefficient of 0.67. Track CHINA SHINEWAY PHARMACEUTICAL GR stock price on the chart and check out the list of the most volatile stocks — is CHINA SHINEWAY PHARMACEUTICAL GR there?
Today CHINA SHINEWAY PHARMACEUTICAL GR has the market capitalization of 7.50 B, it has increased by 2.63% over the last week.
Yes, you can track CHINA SHINEWAY PHARMACEUTICAL GR financials in yearly and quarterly reports right on TradingView.
CHINA SHINEWAY PHARMACEUTICAL GR is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
2877 net income for the last half-year is 678.87 M HKD, while the previous report showed 516.45 M HKD of net income which accounts for 31.45% change. Track more CHINA SHINEWAY PHARMACEUTICAL GR financial stats to get the full picture.
CHINA SHINEWAY PHARMACEUTICAL GR dividend yield was 7.96% in 2023, and payout ratio reached 40.83%. The year before the numbers were 6.30% and 42.96% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 26, 2024, the company has 3.44 K employees. See our rating of the largest employees — is CHINA SHINEWAY PHARMACEUTICAL GR on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHINA SHINEWAY PHARMACEUTICAL GR EBITDA is 1.21 B HKD, and current EBITDA margin is 22.81%. See more stats in CHINA SHINEWAY PHARMACEUTICAL GR financial statements.
Like other stocks, 2877 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHINA SHINEWAY PHARMACEUTICAL GR stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHINA SHINEWAY PHARMACEUTICAL GR technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHINA SHINEWAY PHARMACEUTICAL GR stock shows the buy signal. See more of CHINA SHINEWAY PHARMACEUTICAL GR technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.